Showing results (901-910 of 1,384) with videos related to
Sort By:
Pageof 139
Microbiology Resource Announcements|June 6, 2020
Whole-Genome Sequences of Salmonella Isolates from an Ecological Wastewater Treatment SystemCharles J Connolly, Laura Kaminsky, Gabriella N Pinto, et al.Thrombosis and Haemostasis|January 7, 2022
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with EdoxabanAlexander P Benz, Lizhen Xu, John W Eikelboom, et al.Journal of Cardiovascular Electrophysiology|July 28, 2007
Worsening of symptoms before presentation with vasovagal syncopeRobert S Sheldon, Aaron G Sheldon, Anna Serletis, et al.Journal of Thrombosis and Haemostasis : JTH|October 7, 2011
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trialK-H Liesenfeld, T Lehr, C Dansirikul, et al.American Heart Journal|May 3, 2005
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial FibrillationCharles R Kerr, Karin H Humphries, Mario Talajic, et al.American Journal of Human Genetics|October 27, 1997
Deletion of RB exons 24 and 25 causes low-penetrance retinoblastomaR Bremner, D C Du, M J Connolly-Wilson, et al.Circulation|May 23, 2001
New-onset atrial fibrillation: sex differences in presentation, treatment, and outcomeK H Humphries, C R Kerr, S J Connolly, et al.Oncogene|October 12, 2011
A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumorsE C Piccione, T J Lieu, C F Gentile, et al.The Canadian Journal of Cardiology|May 25, 2013
Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT)Stuart J Connolly, Francois Philippon, Yves Longtin, et al.Journal of the American College of Cardiology|October 1, 2013
The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)Paul A Reilly, Thorsten Lehr, Sebastian Haertter, et al.Pageof 139